Alphabet Inc’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-383
Closed -$62.8K 31
2025
Q4
$62.8K Hold
383
﹤0.01% 29
2025
Q3
$51.2K Hold
383
﹤0.01% 37
2025
Q2
$47.6K Hold
383
﹤0.01% 36
2025
Q1
$48.7K Hold
383
﹤0.01% 39
2024
Q4
$55.2K Hold
383
﹤0.01% 38
2024
Q3
$57K Hold
383
﹤0.01% 39
2024
Q2
$48.3K Hold
383
﹤0.01% 40
2024
Q1
$70.4K Hold
383
﹤0.01% 40
2023
Q4
$68.9K Hold
383
﹤0.01% 42
2023
Q3
$60.9K Hold
383
﹤0.01% 44
2023
Q2
$54.2K Hold
383
﹤0.01% 45
2023
Q1
$64.5K Hold
383
﹤0.01% 47
2022
Q4
$64.8K Hold
383
﹤0.01% 50
2022
Q3
$72K Hold
383
﹤0.01% 49
2022
Q2
$62K Hold
383
﹤0.01% 55
2022
Q1
$72K Hold
383
﹤0.01% 60
2021
Q4
$101K Buy
+383
New +$103K ﹤0.01% 58

Other funds holding RGEN

Alphabet Inc's RGEN Position: Q1 2026 in Review

Alphabet Inc sold out of Repligen (RGEN) in Q1 2026, closing a stake of 383 shares — an estimated $62.8K sold.

Alphabet Inc first reported a position in RGEN in Q4 2021 and held it in 17 quarters. The position peaked at $101K in Q4 2021. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Alphabet Inc reported no remaining Repligen position as of Q1 2026 after selling out during the quarter.
  • Alphabet Inc sold 383 Repligen shares in Q1 2026, an estimated $62.8K.
  • Alphabet Inc first reported a position in Repligen in Q4 2021 and held it in 17 quarters.
  • Alphabet Inc's Repligen position peaked at $101K in Q4 2021.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Alphabet Inc's 13F filing for Q1 2026, filed 8 May 2026.